Rosalind Capital Partners logo

Rosalind Capital Partners

North America, Ontario, Canada, Toronto

Description

Rosalind Capital Partners is an Ontario based venture capital fund that invests in the life sciences sector.

Investor Profile

Rosalind Capital Partners has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (50%)
  • Post Ipo Equity (50%)

Country Focus

  • United States (50%)
  • Israel (50%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Biopharma
  • Health Care
  • Medical
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rosalind Capital Partners frequently co-invest with?

DC
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
HP
North America, New York, United States, New York
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
BC
North America, New York, United States, New York
Co-Investments: 1
EC
North America, New York, United States, New York
Co-Investments: 1
Southpoint Capital Advisors
North America, New York, United States, New York
Co-Investments: 1
AI
North America, New York, United States, Greenport
Co-Investments: 1
KC
Europe, England, United Kingdom, London
Co-Investments: 1
Leadiant Biosciences
North America, Maryland, United States, Gaithersburg
Co-Investments: 1

What are some of recent deals done by Rosalind Capital Partners?

InspireMD

Tel Aviv, Tel Aviv, Israel

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard.

BiopharmaBiotechnologyHealth CareMedical Device
Post Ipo EquityMay 15, 2023
Amount Raised: $113,600,000
Protalix BioTherapeutics

Carmiel, HaZafon, Israel

Protalix is a biopharmaceutical company that is revolutionizing the development and manufacturing of recombinant therapeutic proteins.

BiotechnologyManufacturingPharmaceuticalTherapeutics
Post Ipo EquityMar 12, 2020
Amount Raised: $43,700,000
Soligenix

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownJul 2, 2010
Amount Raised: $5,904,277
Lev Pharmaceuticals

New York, New York, United States

Lev Pharmaceuticals is focused on developing therapeutic products for the treatment of inflammatory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series UnknownOct 23, 2006
Amount Raised: $21,000,000